author-photo

Hui-Chuan Sun

Fudan University
Chinese Ministry of Education

259

Papers

8887

Citations

Citation Trend

Filter By

Papers (259) Sort By

JournalConferenceOthers

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.

2021 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (1)
Factors influencing adjuvant treatment decision making among Chinese patients with hepatocellular carcinoma (HCC): Results of a patient survey.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.

2021 Journal of Clinical Oncology
- Yuxian Bai
- Jianming Xu
- Hui-Chuan Sun
- Chunmei Bai
- Ru Jia
- Yi Li
- Wenjie Zhang
- Lei Liu
- Cheng Huang
- Mei Guan
- Jinghong Zhou
- Weiguo Su
Show All
- Source
- Cite
- Save
Citations (1)
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma.

2021 Experimental hematology & oncology
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 486: A phase Ib/II, open-label study evaluating the efficacy and safety of Toripalimab injection (JS001) or combination with Lenvatinib as a neoadjuvant therapy for patients with resectable hepatocellular carcinoma (HCC)

2021
- Ying-Hong Shi
- Yuan Ji
- Wei-Ren Liu
- Yan-Rui Pang
- Zhen-Bin Ding
- X. Fu
- Xin Zhang
- Cheng Huang
- Yun-Fan Sun
- Xiao-Dong Zhu
- Hui-Chuan Sun
- Jian Zhou
- Jia Fan
Show All
- Source
- Cite
- Save
Citations (0)
Radiological response as a predictor of pathological response to combined tyrosine kinase inhibitor (TKI) and anti-PD-1 antibodies in hepatocellular carcinoma (HCC).

2021 Journal of Clinical Oncology
- Hui-Chuan Sun
- Cheng Huang
- Xiao-Dong Zhu
- Ying-Hao Shen
- Dong Wu
- Yuan Ji
- Ning-Ling Ge
- Yi Chen
- Chang-Jun Tan
- Jian Zhou
- Jia Fan
Show All
- Source
- Cite
- Save
Citations (0)
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

2021 Nature Communications
- Sun Yunfan
- Liang Wu
- Shiping Liu
- Miaomiao Jiang
- Bo Hu
- Kai-Qian Zhou
- Wei Guo
- Yang Xu
- Yu Zhong
- Xiao-Rui Zhou
- Ze-Fan Zhang
- Geng Liu
- Sheng Liu
- Ying-Hong Shi
- Yuan Ji
- Min Du
- Nannan Li
- Guibo Li
- Zhikun Zhao
- Xiaoyun Huang
- Liqin Xu
- Qichao Yu
- David H. Peng
- Shuang-Jian Qiu
- Hui-Chuan Sun
- Michael Dean
- Xiangdong Wang
- Wen-Yuan Chung
- Ashley R. Dennison
- Jian Zhou
- Yong Hou
- Jia Fan
- Xin Rong Yang
Show All
- Source
- Cite
- Save
Citations (3)
Early tumor marker decrease to predict the efficacy of combination therapy with lenvatinib plus anti-PD-1 antibodies in unresectable hepatocellular carcinoma (uHCC).

2021 Journal of Clinical Oncology
- Hui-Chuan Sun
- Xiao-Dong Zhu
- Cheng Huang
- Ying-Hao Shen
- Ning-Ling Ge
- Jin-Jin Zhu
- Bin Xu
- Yi Chen
- Mei-Ling Li
- Jian Zhou
- Jia Fan
Show All
- Source
- Cite
- Save
Citations (1)
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure

2021 Journal of clinical and translational hepatology
Show All
- Source
- Cite
- Save
Citations (2)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号